Summary. Hyperglycaemia decreases (Na +, K+)-ATPase activity in specific tissues by a mechanism whose effects are prevented by aldose reductase inhibitors and by raising plasma myo-inositol. This mechanism was activated and studied in vitro in normal rabbit aortic intima-media. Raising medium glucose to 10 mmol/l for 60 min inhibited a major component of (Na +, K +)-ATPase-mediated 86Rb -/ K + uptake normally operative in resting aortic intima-media in medium containing normal plasma levels of glucose (5 retool/l) and myo-inositol (70 ttmol/l); 20 or 30 mmol/l glucose had no greater effect. This effect occurred under conditions in which the aortic intima-media's normal myo-inositol content is not detectably decreased. The inhibition was prevented by sorbinil (10 p.mol/1) and by raising medium myo-inositol from 70 to 500 gmol/1, which had no effect on (Na +, K+)-ATPase activity when the medium glucose remained at 5 mmol/1. Raising medium glucose selectively inhibited a component of (Na +, K +)-ATPase activity that requires medium myo-inositol, because it is maintained by a regulatory system through rapid basal phosphatidylinositol turnover in a discrete pool, which is replenished by a fraction of basal de novo phosphatidylinositol synthesis that is selectively dependent on myo-inositol uptake. Medium myo-inositol at a normal plasma level became inadequate to maintain this fraction of basal de novo phosphatidylinositol synthesis ([1,3-14C]glycerol incorporation) when the medium glucose was raised. When sorbinil was added raising medium glucose did not alter the ability of 70 umol/l medium myoinositol to maintain the (Na +, K+)-ATPase activity that requires medium myo-inositol. The inhibition caused by raising medium glucose was reproduced by a competitive inhibitor of active myo-inositol transport, scyllo-inositol (500 ~tmol/1). The effect of medium glucose in an elevated plasma level on (Na-, K +)-ATPase activity in aortic intima-media appears to result from increased polyol pathway activity that makes myoinositol uptake at a normal plasma level inadequate to maintain the normal operation of a regulator5, system. Key words: Glucose, (Na +, K+)-ATPase, myo-inositol, phosphatidylinositol, aldose reductase.
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Hyperglycaemia decreases (Na +, K+)-ATPase activity and induces early functional alterations in components of peripheral nerve, kidney, and retina in diabetic animals by a common mechanism whose identifying characteristic is that its effects are prevented by aldose reductase inhibitors and by raising the otherwise normal plasma myo-inositol (MI) level in diabetic animals some 7-fold [1] [2] [3] [4] [5] [6] [7] [8] [9] . It has been assumed that weeks of hyperglycaemia are required to cause the decreased (Na +, K+)-ATPase activities, as well as the functional alterations. Consequently, studies of this mechanism have been restricted to comparisons of metabolite levels and assays of (Na +, K~-)-ATPase in tissues from normal animals and from untreated or treated animals with diabetes of some weeks duration. Such studies suggest that hyperglycaemia acts through increased polyol pathway activity to induce some alteration in MI metabolism that impairs (Na +, K+)-ATPase regulation in the affected tissues [1, 2] ; the increased polyol pathway activity is postulated to alter MI metabolism by impairing MI uptake. Diabetes of some weeks duration decreases MI in the affected tissues and this is prevented by aldose reductase inhibitors and by raising plasma MI [3, [5] [6] [7] [8] ; this has led to the hypothesis that "myoinositol depletion" causes the decreased (Na +, K+) -ATPase activity [2] . However, it is now known that in renal glomeruli the decrease in (Na +, K+)-ATPase activity is present weeks before any detectable decrease in tissue MI [10] , and the latter appears to be a delayed secondary effect.
A mechanism by which impaired MI uptake might decrease (Na +, K+)-ATPase activity in specific tissues without detectable decreases in their normal MI contents was suggested by the observation that normal rab-bit peripheral nerve endoneurium and aortic intimamedia (AIM) require their low normal extracellular fluid (ECF) MI levels during incubations with 5 mmol/l glucose to prevent the inhibition of distinct components of their normal resting (Na +, K+)-ATPase activity and phosphatidylinositol (PI) synthesis, although they do not require medium MI to maintain their high normal M I contents [11, 12] . These phenomena were explained by the demonstration that AIM contains a regulatory system that controls and maintains a major component of normal resting (Na +, K +)-ATPase activity through rapid basal Pi turnover in a discrete pool, and that this pool is maintained by a distinct fraction of basal Pl synthesis that is selectively inhibited when MI uptake is prevented by the absence of medium MI [12] . The polyol pathway is present in rabbit AIM [13] and raising medium glucose from a normal to an elevated plasma level increases AIM sorbitol [14] . We have examined whether raising medium glucose from a normal to an elevated plasma level causes a decrease in normal resting (Na +, K+)-ATPase activity in AIM that can be prevented by adding an aldose reductase inhibitor and by raising the medium M I from a normal plasma level to one 7-fold higher.
Materials and methods
Male, white New Zealand rabbits (2.0 2.5 kg) were fasted overnight, sedated with diazepam (2 mg/kg i. m.), and 90 min later anaesthetized with sodium pcntobarbital (30 mg/kg i.v.) and decapitated. The descending thoracic aorta was rapidly excised and by a previously reported method [| 5, 16] used to prepare 4 tubular segments of aortic intima-media free of adventitia and retaining an intact endothelium with a normal transmission and scanning electron microscopic appearancc. Each AIM segment weighed approximately 30mg. All media to which the tissue was exposed contained 9% clinical grade dextran, average molecular weight 70000 (Sigma Chcmical Co., St. Louis, MO, USA) to provide the oncotic pressure required to maintain this tissuc's normal ultrastructure and pattern of energy metabolism [15] . The aorta was dissected in K.rebs-Henseleit-bicarbonate (KHB) buffer [17] , pH 7.4 at 37~ bubbled with 5% CO2/95% 02, that contained glucose (5 mmol/I) and myo-inositol in a normal rabbit plasma Icvcl, 70 .umol/l [18] . The dissected aorta was cut into 4 tubular segments, designated I to 4 according to their proximal to distal locations in situ. Each anatomically defined segment was systematically rotated into each of the 4 experimental conditions required to compare (Na +, K-)-ATPase activity in paired duplicate samples of AIM from the same aorta in two media that differed only in their levcls of glucose or MI, or in the addition of another compound. (Na +, K+)-ATPase activity was assessed by determinations of ouabain-inhibitable intracellular 86Rb +/K +uptakc, as described below. Transport activity of (Na § K+)-ATPase can be monitored with SrRbt, which substitutes for K" in the activation of ATP hydrolysis and the active transport of K + [19] . The individual AIM samples were equilibrated at 37~ for 30 min in 3 ml of KHB buffer gassed with 5% CO2/air that contained specified levels of glucose and MI in a 10 ml Erlenmeyer flask in a metabolic shaker set at 88 cycles per min. In each experiment duplicate samples were equilibrated in each of the two media to be compared. The samples were then transferred to 3 ml of fresh medium of the same composition to which a tracer level of [3H]sucrose, 0.64 gCi/ml, 9.5 Ci/mmol, had been added, along with ouabain (0.2 mmol/l) in one of the duplicate samples to be incubated with each medium, and the samples pre-incubated for 10min. A tracer quantity of [86Rb + ]RbCI, 0.25 .tLCi/ml, 0.46 Ci/mmol, was then added to each flask and the samples incubated for 20 rain. The tissue was then rapidly removed, drained on filter paper, weighed, and transferred into 2 ml of Protosol (New England Nuclear, Boston, Mass, USA) in a glass scintillation vial and digested for 16 h at room temperature; 0.1 ml of H202 was then added and the samples incubated for 1 h at 37~ Econofluor 2 (New England Nuclear) was added and thc sample counted for 86Rb ~ and 3H in a liquid scintillation spectrometer with an external standard. The 86Rb ~ counts in the sample were corrected for 86Rb + in cxtracellular fluid by means of the [3H]sucrose recovcred in the sample and the ratio of S6Rb+ to 3H counts in the medium. The medium K ~ and the medium SrRb+ counts/l were determined and these data used to express the corrected recovery of 86Rb+ in the sample as .ttmol 86Rb+/K+ uptake.g -1 9 20 min -1. The differcnce between the uptake of the two samples incubated in the absence and presence of ouabain was used as an estimate of the (Na-, K+)-ATPase-mediated 86Rb+/K+ uptake. The values obtained by this method were linear in assays conducted over 10 to 20 min in paired samples from the same aorta. KHB buffer contains normal plasma levels of K + and Na ~ 117].
To assess basal de novo PI synthesis the 4 AIM samples from each aorta were used to provide two paired samples, which were equilibrated for 31) min in 6 ml of KHB buffer containing specified concentrations of glucose and M1, and then transferred to fresh medium of the same composition to which 0.1mmol/l [1,3-14C]glycerol, 55 mCi/ml, had been added, and the samples incubated for 15 min at 37~ while being continuously gassed with 5% CO2/air. The tissue was then rapidly removed, frozen in liquid N2 that had becn partially evaporated to its freezing point, weighed, and powdered in liquid N2, as previously described [12] . Using methods previously described [12] the phospholipids were extracted, PI isolated by two-dimensional thin layer chromatography, and the PI counted to assess the [1,3-14C]glycerol incorporated into PI.
The sources of the material used were: ouabain (Sigma Chemical Co., St.Louis, Mo, USA); myo-inositol (Pfhanstiehl I.abs Inc., Waukegan, Ill, USA); scyllo-inositol (Calbiochem, La Jolla, Calif.. 
Statistical analysis
The mean A + SEM between paired samples in each group of paired experiments was analysed for significance by a paired t test analysis. The difference between the mean A + SEM of one group of paired experiments and another group was analysed for significance by an unpaired t test analysis.
Results
Normal resting (Na +, K+)-ATPase activity in AIM is comprised of two distinct components that differ in a requirement for ECF myo-inositol; one component is selectively inhibited when AIM is deprived of medium MI for 30 min leaving another component that remains constant for at least an additional 45 min [12] . In AIM incubated with 5 mmol/l glucose, medium M I in a normal plasma level (70 lamol/i) is adequate to maintain the component that requires ECF MI, whose magnitude is constant once the threshold requirement for its maintenance (50 gmol/l) is met and is unaltered by fur- Table 1 . Effects of medium myo-inosiu)l on (Na-, K*)-ATPase activity in normal resting aortic intima-media incubated with 5 mmol/I glucose (Na +, K")-ATPasc-mcdiated 86Rb /K-uptake (.umol 9 g-I. 20 ther increases in medium MI up to at least 500 lamol/l. Under the conditions employed in this study these two components of normal resting (Na +, K+)-ATPase activity were readily distinguishable. When AIM was equilibrated and incubated in KHB buffer containing 5 mmol/l glucose (and the 9% dextran present in all media) the addition of 70 ttmol/l MI to the medium maintained a large component of (Na +, K+)-ATPasemediated 86Rb+/K+ uptake that was absent in paired samples deprived of medium MI (Table 1 ,a). Raising the medium MI from 70 to 500 ttmol/l had no effect on (Na +, K+)-ATPase-mediated 86Rb+/K+ uptake in AIM incubated with 5mmol/1 glucose (Table l,b) .
(The non-ouabain-inhibitable 86Rb~/K+ uptake in AIM incubated with 5 mmol/l glucose was not significantly different in medium lacking or containing 70 .ttmol/l MI, as shown in Table 1 ,c).
In AIM deprived of medium MI raising medium glucose from 5 to 30 mmol/1 had no effect on (Na +, K+)-ATPase activity (Table 2, a). However, in AIM provided with 70.ttmol/1 medium myo-inositol raising medium glucose from 5 to 10 mmol/I caused a marked decrease in (Na +, K+)-ATPase-mediated 86Rb+/K+ uptake (Table 2 ,b), and raising the medium glucose to 20 or 30 mmol/1 had no greater effect (Table 2,c and d). Raising the medium glucose to 10 mmol/l inhibited a component of (Na +, K +)ATPase-mediated 86Rb +/K + uptake that was not significantly different from that maintained by medium MI in a normal plasma level in AIM incubated with 5 mmol/1 glucose (1.36_0.25vs 1.34_+0.13 I_tmol.g-t-20min -t, Tables2,b and 1,a). Thus, in AIM provided with medium MI in a normal plasma level raising medium glucose from 5 to 10 mmol/l for 60 min selectively and completely inhibits the major component of normal resting (Na +, K+) -ATPase activity that requires ECF MI and is normally maintained by medium MI in a normal plasma level.
In AIM incubated with 30 retool/1 glucose raising Table 4 . Effect of raising medium glucose on (Na +, K +)-ATPase activity in aortic intima-media in medium containing a normal plasma myoinositol (MI) level when an aldose reductase inhibitor is present (Table 4 ,a). The addition of sorbinil (10 I.tmol/1) had no effect on (Na +, K+)-ATPase activity in AIM incubated with 5 mmoi/l glucose and 70 ~mol/1 MI (Table 4 ,b), and it does not appear to affect (Na +, K+)-ATPase activity in AIM unless it is exposed to medium glucose in an elevated plasma level. Tolrestat (1 .ttmol/l), another aldose reductase inhibitor with a significantly different structure [20] , also prevented the effect of 30mmol/l glucose on (Na +, K+)-ATPase activity in AIM provided with 70 I.tmol/l medium Ml (Table 4 , c). These observations suggest that raising medium glucose from a normal to an elevated plasma level causes medium MI in a normal plasma level to become inadequate to maintain a specific component of normal resting (Na +, K ~-)-ATPase activity in AI M, and that this effect requires aldose reductase activity. Scyllo-inositoi is a competitive inhibitor of active MI transport [21, 22] that is normally present in rabbit plasma in very low levels, < 5 amol/l [18] . In AIM incubated with 5 mmol/1 glucose in medium lacking MI, adding 500~tmol/1 scyllo-inositol has no effect on (Na*, K*)-ATPase activity [12] . However, as shown in TableS,a, in AIM incubated with 5 mmol/l glucose and 70 .umol/l MI the addition of 500 .ttmol/l scylloinositol inhibited a component of (Na*, K*)-ATPasemediated 86Rb +/K + uptake, 1.27_+ 0.36 I, tmol 9 g-1.20 min-1, not significantly different from those inhibited by raising the medium glucose to 10-30 mmol/1 (see Table 2 ,b-d). This effect of 500 ~tmol/l scyllo-inositol on (Na +, K+)-ATPase activity in AIM incubated with normal plasma levels of glucose and M I was prevented when the medium MI was raised from 70 to 500 .umol/l Table 5 ,b), but was not prevented by the addition of 10 .umol/1 sorbinil (Table 5 ,c). Thus, in AIM incubated with normal plasma levels of glucose and MI the effect of an elevated medium glucose on a specific component of normal resting (Na*, K')-ATPase activity can be reproduced by the addition of a competitive inhibitor of active MI transport that makes medium M I in a normal plasma level inadequate for its maintenance.
Normal basal de novo PI synthesis in AIM, as assessed by the incorporation of 0.1 mmol/l [1,3-14C]glycerol into PI in AIM incubated in KHB buffer containing normal plasma levels of glucose and MI, is comprised of two distinct fractions [12] . One fraction does not require medium MI; it forms glycerol-labelled PI during a 15 min pulse that remains stable during chases of at least 30 rain. Another distinct fraction requires medium MI and is maintained by 70 .ttmol/! MI when AIM is incubated with 5 mmol/l glucose; this fraction of basal de novo PI synthesis forms an additional component of glycerol-labelled PI during a 15min pulse that completely disappears during a 30 min chase [12] . In AIM deprived of medium MI rais- Table 6 . Effects of raising medium glucose on [l,3-t4C]glycerol incorporation into phosphatidylinositol (PI) in the absence and presence of medium myo-inositol (MI) in a normal plasma level (Table 6 , a). When these experiments were repeated with 70 ~tmol/l M! added to the media, the samples incubated with 5 mmol/l glucose exhibited the expected increase in [l,3-14C]glycerol incorporation into PI, and raising the medium glucose from 5 to 30 mmol/l caused a significant decrease in paired samples (Table 6 ,b). Thus, in AIM provided with medium MI in a normal plasma level raising the medium glucose from a normal to an elevated plasma level selectively inhibits the fraction of normal basal de novo PI synthesis that requires ECF MI to maintain it. When 0.1 mmol/l [1,3-14C]glycerol incorporation into PI during a 15 min incubation was compared in paired AIM samples incubated in medium containing either 5 mmol/1 glucose and 70 umol/l MI or 30 mmol/1 glucose and 500 ~tmol/l MI there was no significant difference; the mean A + SEM between the paired samples was -0.005 + 0.003 .umol [a,3J4C]glycerol incorporation into PI-kg -1-15 min -1, (n =7). Thus, in AIM exposed to medium glucose in an elevated plasma level (30mmol/l), raising the medium MI from 70 to 500.ttmol/l prevents the inhibition of the fraction of basal de novo PI synthesis that requires ECF MI and maintains total basal de novo P! synthesis at normal levels.
Discussion
A major component of the (Na +, K+)-ATPase activity normally operative in resting AIM in medium containing normal plasma levels of glucose, HMI, Na +, and K + was inhibited when the medium glucose was raised from 5 to 10 mmol/1 for 40 min prior to, and during, a 20min assessment of (Na +, K+)-ATPase-mediated 86Rb 4/K+ uptake, and raising medium glucose to 20 or 30 mmol/l had no greater effect, in AIM exposed to 30 mmol/l glucose this inhibition was prevented by two structurally different aldose reductase inhibitors, sorbinil (10 I, tmol/l) and tolrestat (1 .ttmol/l), and also by raising the medium MI from a normal plasma level to one some 7-fold higher. When the medium glucose remained at 5 mmol/l, adding sorbinil or increasing medium MI from 70 to 500.ttmol/1 had no effect on (Na +, K+)-ATPase activity. These observations suggest that the mechanism by which hyperglycaemia initially decreases (Na +, K +)-ATPase activity in components of peripheral nerve, kidney, and retina in diabetic animals [1, 2] can be acutely activated and studied in vitro in AIM, a model arterial wall. Raising the medium glucose to a threshold elevated plasma level for 60 min selectively and completely inhibited the component of normal resting (Na +, K+) -ATPase activity that is maintained by a regulatory system recently identified in AIM. This system controls a distinct component of resting (Na +, K § )-ATPase activity through rapid basal PI turnover in a discrete pool, which is not attributable to the use of this pool for polyphosphoinositide formation and appears to reflect rapid basal PI hydrolysis [12] . The stimulus for the rapid basal PI turnover in a discrete pool is postulated to be endogenously released adenosine [1] , a "local hormone" released by tissues in a manner that varies with their biological activity and energy state [23] . MI uptake is required to maintain the normal operation of this regulatory system, because the discrete PI pool turns over completely within 30 min in resting AIM and is replenished by a distinct fraction of normal basal de novo PI synthesis that is selectively inhibited when MI uptake is prevented by depriving the tissue of medium MI, which results in the inhibition of the component of resting (Na +, K +)-ATPase activity normally maintained by this system within 30 min [12] . When AIM is incubated with 5 mmol/l glucose, medium MI in a normal plasma level is adequate to maintain the fraction of basal de novo PI synthesis that replenishes the discrete PI pool, and the magnitude of the component of (Na § K+) -ATPase activity maintained by the regulatory system is constant and independent of the medium MI concentration over the range of 50 to at least 500 ~tmol/I. Our observations suggest that raising medium glucose from 5 to 10-30 mmol/1 causes the decrease in normal resting (Na +, K+)-ATPase activity by acting in a manner that requires aldose reductase activity to make medium MI in a normal plasma level inadequate to maintain the normal operation of the regulatory system, presumably by increasing polyol pathway activity that impairs ECF MI uptake at a normal plasma level. This formulation is supported by the following observations. In AIM provided with medium M I in a normal plasma level raising the medium glucose to an elevated plasma level selectively inhibited the fraction of basal de novo PI synthesis and the component of normal resting (Na +, K +)-ATPase activity that require ECF MI to maintain them, but when the medium Ml was raised to 500 ~tmol/l the effects of 30 mmol/l glucose on normal basal de novo PI synthesis and (Na +, K+)-ATPase activity were prevented. When sorbinil or tolrestat was added during incubations with 30 mmol/l glucose, medium MI in a normal plasma level remained adequate to maintain the component of (Na +, K +)-ATPase activity that requires ECF MI. Raising medium glucose from a normal to an elevated plasma level during a 60 rain incubation was previously shown to cause increases in sorbitol in AIM [14] , and increased polyol pathway activity is known to impair active M1 transport in a number of tissues [24, 25] , although the basis of this effect is still obscure. Finally, in AIM incubated with normal plasma levels of glucose and MI the addition of scyllo-inositol (500 .umol/l), a competitive inhibitor of active MI transport [21, 22] , reproduced the effect of raising the medium glucose level and inhibited the component of (Na +, K +)-ATPase activity that is normally maintained by the regulatory system by making medium MI in a normal plasma level inadequate for its maintenance.
Medium glucose in an elevated plasma level inhibited a major component of normal resting (Na +, K+)-ATPase activity under conditions in which there is no detectable decrease in tissue MI. The high normal M I content of AIM, 5.80+ 0.43 mmol/kg, does not require medium MI to prevent any significant decrease during a 60 rain incubation with glucose in a normal or in an elevated plasma level [12, 14] , and it is not significantly increased when 70 or 500 pmol/l MI is added during incubations with 5mmol/l glucose [12] . The major mechanisms by which most tissues maintain high MI contents that are not dependent on dietary MI are endogenous MI synthesis and the recovery of MI from phosphoinositide turnover [26] , and the quantitative importance of M1 uptake as a source of M1 is unclear in most tissues. Although M I uptake does not appear to bc essential for the maintenance of the major MI pools in AIM, the fraction of basal PI synthesis that replenishes the discrete PI pool behaves as though it is localized in a specific cell type or subcellular site where it requires a very small MI pool that is peculiarly dependent on ECF MI uptake for its maintenance. (It is of note that PI synthesis occurs in plasma membrane, as well as in endoplasmic reticulum, and that a rat plasma membrane PI synthetase with a remarkably low K~n for MI, 67 .umol/l, has recently been identified [27] ). The effect of an elevated medium glucose on basal de novo PI synthesis in AIM was restricted to a specific fraction, it did not inhibit the major fraction of the tissue's normal basal de novo PI synthesis that does not require ECF M1, which is the fraction that accounts for all of the [l,3-t4(']glycerol incorporation into polyphosphoinositides in resting AIM [12] . This is in accordance with the evidence that the effect of diabetes on (Na +, K+)-ATPase activity in peripheral nerve is not associated with an inhibition of polyphosphoinositide synthesis or turnover [28] .
Our observations would suggest that in those tissues in which hyperglycaemia causes a decrease in (Na +, K+)-ATPase activity that is prevented by aldose reductase inhibitors and by raising plasma MI it initially acts by increasing polyol pathway activity and impairing MI uptake at a normal ECF MI level, which inhibits a specific component of normal (Na-, K+)-ATPase activity, because some tissue components contain a (Na -, K+) -ATPase regulator 3, system like that identified in AIM, which requires ECF MI uptake to maintain its normal operation. (Our observations would also suggest that this initial effect of hyperglycaemia probably occurs without a detectable decrease in tissue MI and with only selective alterations in PI synthesis and phosphoinositide metabolism, which agrees with observations in renal glomeruli and perpheral nerve from diabetic rats [10, 28] ). There is evidence suggesting that this formulation is probably valid in peripheral nerve endoneurium, in which raising medium glucose from 5 to 30 mmol/l causes an acute inhibition of active MI transport that is largely prevented by 10 pmol/1 sorbinil [24] . For depriving endoneurium of medium MI inhibits a specific fraction of normal basal PI synthesis and a distinct component of normal resting (Na +, K+)-ATPase activity that appears to be controlled by a regulatory system like that in AIM (11).
The ability of a rise in medium glucose to 10 mmol/l for 60 rain to activate this mechanism for (Na +, K+)-ATPase inhibition in AIM is of note. This may explain why insulin treatment that does not persistently prevent any detectable hyperglycaemia is ineffective in preventing the effects attributed to this mechanism in peripheral nerve [6] . This observation also raises a serious question about the untested assumption that some weeks of hyperglycaemia are required to cause decreased (Na +, K+)-ATPase activity in components of nerve, kidney, and retina, which has been the premise on which the design of all previous studies of this mechanism have been based. Until this question is resolved caution is required in interpreting alterations observed in these tissucs after some weeks of diabetes, since there is the possibility that some of these alterations reflect secondary effects of, and complex adaptations to, the initial effects of hyperglycaemia in these tissues.
